A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder

Journal of the American Academy of Child and Adolescent Psychiatry
S E SwedoN E Rosenthal

Abstract

To evaluate the efficacy of light therapy for the treatment of pediatric seasonal affective disorder (SAD). 28 children (aged 7 to 17 years) at two geographically distinct sites were enrolled in a double-blind, placebo-controlled, crossover trial of bright-light treatment. Subjects initially entered a week-long baseline period during which they wore dark glasses for an hour a day. They were then randomly assigned to receive either active treatment (1 hour of bright-light therapy plus 2 hours of dawn simulation) or placebo (1 hour of clear goggles plus 5 minutes of low-intensity dawn simulation) for 1 week. The treatment phase was followed by a second dark-glasses phase lasting 1 to 2 weeks. After this phase, the children received the alternate treatment. Response was measured using the parent and child versions of the Structured Interview Guide for the Hamilton Depression Rating Scale, Seasonal Affective Disorders version (SIGH-SAD). Data were analyzed as change from baseline. SIGH-SAD-P total depression scores were significantly decreased from baseline during light therapy compared with placebo (one-way analysis of variance, rho = .009), and no differences were found between the placebo and control phases. Subscores of atypica...Continue Reading

References

Apr 1, 1991·The American Journal of Psychiatry·D A OrenN E Rosenthal
Mar 1, 1986·The American Journal of Psychiatry·N E RosenthalT A Wehr
Jul 1, 1995·The American Journal of Psychiatry·S E SwedoN E Rosenthal
Dec 8, 1993·JAMA : the Journal of the American Medical Association·N E Rosenthal
Mar 1, 1993·Journal of the American Academy of Child and Adolescent Psychiatry·M A Carskadon, C Acebo
Nov 1, 1996·The American Journal of Psychiatry·M TermanD C Ross

❮ Previous
Next ❯

Citations

Aug 10, 2006·Psychopharmacology·Khrista BoylanBoris Birmaher
Jul 19, 2012·Journal of Neural Transmission·Krzysztof KrystaIrena Krupka-Matuszczyk
May 8, 2008·Current Neurology and Neuroscience Reports·Kyle P Johnson, Beth A Malow
Mar 25, 2004·Current Psychiatry Reports·Mani Pavuluri, Boris Birmaher
Sep 11, 2008·Current Treatment Options in Neurology·Kyle P Johnson, Beth A Malow
Feb 1, 1997·Journal of the American Academy of Child and Adolescent Psychiatry·C A GlodY Ito
Feb 25, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·J N GieddN E Rosenthal
Sep 15, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·Y Meesters
Oct 12, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·A SouranderH Helenius
Jun 7, 2002·Journal of the American Academy of Child and Adolescent Psychiatry·Kathleen Myers, Nancy C Winters
Nov 5, 1998·Lancet·T Partonen, J Lönnqvist
Oct 24, 1998·Journal of the American Academy of Child and Adolescent Psychiatry
May 20, 2015·European Child & Adolescent Psychiatry·Stephanie GestTanja Legenbauer
Jun 29, 2013·Child and Adolescent Psychiatric Clinics of North America·Charles W Popper
Aug 13, 2011·Medical Hypotheses·Sarah HeilerMartin Holtmann
Feb 21, 2009·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Dec 1, 2007·Journal of the American Academy of Child and Adolescent Psychiatry·Boris BirmaherJennifer Medicus
Sep 6, 2006·Child and Adolescent Psychiatric Clinics of North America·David A Brent, Boris Birmaher
Jan 1, 1994·Current Problems in Pediatrics·S E SwedoA J Allen
Apr 6, 2004·The Psychiatric Clinics of North America·Robert L FindlingChristine Demeter
Jan 7, 2015·Acta Physiologica·A S UrrilaM Marttunen
Jan 29, 2014·Medical Hypotheses·Stephanie GestMartin Holtmann
Nov 16, 2010·Journal of Affective Disorders·Małgorzata Janas-KozikJanusz K Rybakowski
Jul 18, 2018·Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie·Inken Kirschbaum-LeschMartin Holtmann
Jan 6, 2010·The Physician and Sportsmedicine·Robert H Howland
May 2, 2003·Chronobiology International·Andres Magnusson, Diane Boivin
Jul 26, 2005·CNS Spectrums·Andres Magnusson, Timo Partonen
Oct 4, 2006·The Medical Journal of Australia·Anthony F JormAmy J Morgan
Oct 10, 2021·Journal of Pediatric Psychology·Kayla N LaRosaValerie McLaughlin Crabtree

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Child and Adolescent Psychiatry
M B KellerJ P McCafferty
Journal of the American Academy of Child and Adolescent Psychiatry
M A Carskadon, C Acebo
Journal of the American Academy of Child and Adolescent Psychiatry
N D RyanD Mazzie
© 2021 Meta ULC. All rights reserved